Enhanced Face Detection Based on Haar-Like and MB-LBP Features

The effective real-time face detection framework proposed by Viola and Jones gained much popularity due its computational efficiency and its simplicity. A notable variant replaces the original Haar-like features with MB-LBP (Multi-Block Local Binary Pattern) which are defined by the local binary pattern operator, both detector types are integrated into the OpenCV library. However, each descriptor and its evaluation method has its own set of strengths and setbacks. In this paper, an enhanced two-layer face detector composed of both Haar-like and MB-LBP features is presented. Haar-like features are employed as a coarse filter but with a new evaluation involving dual threshold. The already established MB-LBPs are arranged as the fine filter of the detector. The Gentle AdaBoost learning algorithm is deployed for the training of the proposed detector to reach the classification and performance potential. Experiments show that in the early stages of classification, Haar features with dual threshold are more discriminative than MB-LBP and original Haar-like features with respect to number of features required and computation. Benchmarking the proposed detector demonstrate overall 12% higher detection rate at 17% false alarm over using MB-LBP features singly while performing with ×3 speedup

Spondylarthrite ankylosante au Sénégal: aspects épidémiologiques, diagnostiques, thérapeutiques et évolutifs au Centre Hospitalier Universitaire Aristide LeDantec de Dakar

Introduction: la spondylarthrite ankylosante (SA) est une maladie évolutive, pouvant s'aggraver par une invalidité. Le but de notre étude est de décrire les aspects épidémiologiques, diagnostiques, thérapeutiques et évolutifs de la SA dans le service de rhumatologie du Centre Hospitalier Universitaire Aristide LeDantec à Dakar. Méthodes: il s´agissait d´une étude transversale descriptive et analytique, avec un recueil de données à la fois prospectif et rétrospectif sur une période de 8 ans, entre janvier 2012 et décembre 2020, sur des patients atteints de SA de diagnostic établi en accord avec les critères diagnostiques d´Amor, de l´ESSG (European Seronegative Spondylarthropathy Group), d´ASAS (Assessment of Spondyloarthritis International Society) et les critères de New York modifié pour la SA. Les données ont été recueillies par le biais d'un questionnaire structuré et analysées à l´aide du logiciel SPSS25 (Statistical Package for the Social Sciences). Résultats: six cent quarante-sept (647) patients ont répondu aux critères d´inclusions; 414 femmes et 233 hommes soit un sex ratio de 1,77F/1H. Différentes formes symptomatiques étaient obtenues: les formes axiales (55,65%), les formes mixtes (44,35%) et les formes systémiques avec manifestation extra-articulaires: uvéites (12,21%), insuffisance aortique (5,71%) et maladie fibrobulleuse des poumons (3,86%). Soixante pourcent (60%) des patients étaient sous antiinflammatoires non stéroïdiens (AINS), 47% sous méthotrexate et 0,92% sous biothérapie. Les indices d´activité de la maladie, les indices fonctionnels et les indices de la qualité de vie ont permis le suivi de la maladie. Conclusion: nos résultats ont montré une prédominance féminine. Les formes axiales étaient les plus représentées. Plus de la moitié de nos patients étaient sous antiinflammatoires, 47% sous méthotrexate et 0,92% sous biothérapie. Cette étude a permis de comprendre le poids de la SA dans les spondyloarthrites et son évolution dans le temps

Age-dependent pharmacokinetics and effect of roscovitine on Cdk5 and Erk1/2 in the rat brain.

Roscovitine is a cyclin-dependent kinase (Cdk) and signal-regulated kinase (Erk1/2) inhibitor that has been shown to be effective against several cancer types including brain tumors. We have shown previously that roscovitine crosses the blood brain barrier (BBB) and is rapidly eliminated from both plasma and brain in adult rats. However, age-dependent kinetics and its effects on the brain have not been reported. In the present study, we investigated the pharmacokinetics of roscovitine in adult and in 14 days old rats after the administration of a single dose of 25 mg/kg. Moreover, we studied the effect of the drug on Cdk5 and Erk1/2 activities in three brain regions, hippocampus, frontal cortex and cerebellum. The pharmacokinetics of roscovitine followed a two-compartment model in both plasma and brain in both adult and young rats. The terminal elimination half-life was 7 h in brain as well as in plasma in rat pups compared to < 0.5 h observed in adult rats. Brain exposure expressed as AUC brain/AUC plasma was 100% in rat pups compared to 20% found in adult rats. Roscovitine induced a significant Cdk5 inhibition and significant Erk1/2 activation in all studied pups brain regions at 2 h. This is the first study describing age-dependent pharmacokinetics of roscovitine and showing the high brain exposure of infant rats to the drug. Thus, roscovitine may be a promising candidate for the treatment of brain tumors in children

Determination of the concentration of thiocyanate ion in smokers’ blood using photo-spectroscopy

  In this research, the concentration of thiocyanate ion in serum has been investigated, thiocyanate has negative effects on human body when it increasses higher than specific limit, this ion is produced by the metabolism of cyanide which exist in cigarette smoke. Spectrophotometric method has been used in the visible range at λ=460 nm, the formation of the complex between thiocyanate and reagent Ferric chloride (FeCl3) have been made in an ideal parameters such as temperature 25 ºC, time=15 min, pH=4.4, volume of citrate buffer=0.75 ml, volume of reagent (FeCl3) =1 ml and concentration of reagent = 0.02 mg/ml. The selected method showed good accuracy and precision, the accuracy of the method has been validated with R=99.3%, and the precision of relative standard deviation was (RSD % . The concentration of thiocyanate has been studied in a sample of 240 non-smokers’ and in a sample of 240 smokers’, these samples have been divided into different age groups. The maximum concentration of thiocyanate was 89.49 µmol/L in the fourth group (>50 years) of the non-smokers’, and the maximum concentration of thiocyanate was 190.27 µmol/L in the fourth group (>50 years) of the smokers’. The maximum concentration of thiocyanate was 91.647 µmol/L in the non-smokers’ males and 86.623 µmol/L for the non-smokers’ females, whereas the concentration of thiocyanate was 204.53 µmol/L in the male smokers’ and 167.33 µmol/L in the female smokers’

Co-infection in patients with COVID-19 in Tripoli Northern Lebanon: germs involved and antibiotic sensitivity profile.

Introduction: A considerable proportion of patients hospitalized with coronavirus disease 2019 (COVID-19) acquired bacterial infections. The aim of this study was to investigate the etiology and antimicrobial resistance of bacterial co-infection for more informed antimicrobial treatment. Methods: This retrospective study reviewed electronic medical records of all the patients hospitalized with COVID-19 in the Northern Lebanon, Nini Hospital between august 2020-september 2021. According to the inclusion and exclusion criteria, patients who acquired bacterial infection were enrolled. Demographic, etiology and antimicrobial resistance data of the co-infection were collected. Results: The rate of infection by Gram-negative bacteria was 61.7%, while the rate of infection by Gram-positive bacteria was 23.4%. Escherichia coli was the dominant species isolated in this study (25.5%), followed by Candida spp (14.9%). With regard to fungal infection, there were 14.9% cases of yeast infection. The respiratory infection was the majority (42.5%), followed by blood infection (32%) and urine infection (25.5%). The analysis of antibiotics sensitivity results showed us that 44.4% of isolated Enterobacteriaceae were resistant to carbapenem, 16.66% were secretors of ESBL. We noted that 27.77% of Enterobacteriaceae were XDR. All isolates of Staphylococcus aureus were resistant to the methicillin. Conclusion: Bacterial co-infection may occur in patients hospitalized with COVID-19 and lead to high mortality. Gram-negative bacteria, especially Escherichia coli, S. maltophilia, and P. aeruginosa were the main bacteria, and the resistance rates of the major isolated bacteria were generally high. Keywords: COVID-19, co-infection, antibioresistance, Lebanon

Expansion and Activation Kinetics of Immune Cells during Early Phase of GVHD in Mouse Model Based on Chemotherapy Conditioning

In the present paper, we have investigated early pathophysiological events in graft-versus-host disease (GVHD), a major complication to hematopoietic stem cell transplantation (HSCT). BLLB/c female mice conditioned with busulfan/cyclophosphamide (Bu-Cy) were transplanted with allogeneic male C57BL/6. Control group consisted of syngeneic transplanted Balb/c mice. In allogeneic settings, significant expansion and maturation of donor dendritic cells (DCs) were observed at day +3, while donor T-cells CD8+ were increased at day +5 (230%) compared to syngeneic HSCT. Highest levels of inflammatory cytokines IL-2, IFN-gamma, and TNF-alfa at day +5 matched T-cell activation. Concomitantly naïve T-cells gain effecr-memory phenotype and migrated from spleen to peripheral lymphoid organs. Thus, in the very early phase of GHVD following Bu-Cy conditioning donor, DCs play an important role in the activation of donor T cells. Subsequently, donor naïve T-cells gain effector-memory phenotype and initiate GVHD

A general covalent binding model between cytotoxic selenocompounds and albumin revealed by mass spectrometry and X-ray absorption spectroscopy

Selenocompounds (SeCs) are promising therapeutic agents for a wide range of diseases including cancer. The treatment results are heterogeneous and dependent on both the chemical species and the concentration of SeCs. Moreover, the mechanisms of action are poorly revealed, which most probably is due to the detection methods where the quantification is based on the total selenium as an element. To understand the mechanisms underlying the heterogeneous cytotoxicity of SeCs and to determine their pharmacokinetics, we investigated selenium speciation of six SeCs representing different categories using liquid chromatography-mass spectrometry (LC-MS) and X-ray absorption spectroscopy (XAS) and the cytotoxicity using leukemic cells. SeCs cytotoxicity was correlated with albumin binding degree as revealed by LC-MS and XAS. Further analysis corroborated the covalent binding between selenol intermediates of SeCs and albumin thiols. On basis of the Se-S model, pharmacokinetic properties of four SeCs were for the first time profiled. In summary, we have shown that cytotoxic SeCs could spontaneously transform into selenol intermediates that immediately react with albumin thiols through Se-S bond. The heterogeneous albumin binding degree may predict the variability in cytotoxicity. The present knowledge will also guide further kinetic and mechanistic investigations in both experimental and clinical settings

Inhibition of proteasome deubiquitinating activity as a novel cancer therapy

Ubiquitin-tagged substrates are degraded by the 26S proteasome, which is a multisubunit complex comprising a proteolytic 20S core particle capped by 19S regulatory particles. The approval of bortezomib for the treatment of multiple myeloma validated the 20S core particle as an anticancer drug target. Here we describe the small molecule b-AP15 as a previously unidentified class of proteasome inhibitor that abrogates the deubiquitinating activity of the 19S regulatory particle. b-AP15 inhibited the activity of two 19S regulatory-particle-associated deubiquitinases, ubiquitin C-terminal hydrolase 5 (UCHL5) and ubiquitin-specific peptidase 14 (USP14), resulting in accumulation of polyubiquitin. b-AP15 induced tumor cell apoptosis that was insensitive to TP53 status and overexpression of the apoptosis inhibitor BCL2. We show that treatment with b-AP15 inhibited tumor progression in four different in vivo solid tumor models and inhibited organ infiltration in an acute myeloid leukemia model. Our results show that the deubiquitinating activity of the 19S regulatory particle is a new anticancer drug target.CancerfondenRadiumhemmets forskningsfonderVetenskapsrådetStrategiska forskningsstiftelsenVinnovaEuropean Union CHEMORES, Frame program 6 (LSHC-CT-2007-037665)Swedish Children Cancer SocietyAccepte

Platelet-Rich Plasma in Regenerative Medicine: Possible Applications in Management of Burns and Post-Burn Scars: A Review

Contribution of platelets in tissue regeneration and their possible application in regenerative medicine, which is primarilymediated via secretion of granular components following platelet activation, has been well established in the recent decades.Therefore, platelet rich plasma (PRP), as a portion of plasma with higher concentrations of platelets than the baseline level,is now an attractive therapeutic option in various medical fields mainly for tissue repair and regeneration following injuries.Burn injuries are devastating trauma with high rate of morbidities affecting several aspects of the patient’s life. They requirea long-time medical care and high costs. However, even following the best treatment procedures, post-burn scars areinevitable consequence of burn healing process. Therefore, development of new treatment modalities for both burn healingand prevention of post-burn scar establishment seems to be necessary. Regarding the well-known role of PRP in woundhealing, here we aimed to provide a comprehensive insight in the possible application of PRP as an adjuvant therapy forthe management of burn injuries and subsequent scars. In terms of the following keywords (individually or in combination),original/review articles were searched in PubMed, Scopus, and Google Scholar databases from 2009 to 2021: platelet richplasma, PRP therapy, platelet biology, platelet function, burn healing, burn scar, scar formation, burn management, woundhealing, regenerative medicine. All type of articles or book chapters in English language and relevant data were included inthis review. This review initially focused on PRP, its mechanisms of action, preparation methods, and available sources. Then,pathophysiology of burns and subsequent scars were discussed. Finally, their current conventional therapeutic modalities andimplication of PRP in their healing process were highlighted